Read More

Cannabist execs highlight progress on ‘turnaround’ plan despite $200M loss

Executives with The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) during the company’s quarterly earnings call said they’re about halfway through a “turnaround” plan to make the company profitable, but didn’t mention the financial filing this week which reported a $205 million net loss for the business last… …

Read More

Neural Therapeutics to list on Canadian Stock Exchange after raising C$518,000

Toronto-based Neural Therapeutics (CSE: NURL) announced on Thursday a twofold milestone, with both the completion of a C$518,500 capital raise and the receipt of formal permission from the Canadian Securities Exchange to begin listing its shares for trading, another sign that the international psychedelics industry is making slow but steady… …

Read More

Cresco looks for Kentucky boost, takes hard pass on New York retail

Illinois-based Cresco Labs (CSE: CL) (OTCQX: CRLBF) isn’t rushing to open recreational retail cannabis sales in New York anytime soon, but is “excited” about its entrance into Kentucky’s medical marijuana scene this coming year, company leadership said during the quarterly earnings call Wednesday. CEO Charlie Bachtell repeatedly referred to the …